COMP <GO>
CLGN vs HSCS // ENTERPRISE SCALE & MARKET CAP
CollPlant Biotechnologies Ltd (NASDAQ) VS. HeartSciences Inc. (NASDAQ) • 15-METRIC TALLY: CLGN 4
— HSCS 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: HSCS
LAST: $4.40 (+11.39%) • MKT CAP: $12.7M
market-cap
$12.7M
LAST: $3.61 (+7.12%) • MKT CAP: $17.5M
market-cap
$17.5M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLGN VS. HSCS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLGN | HSCS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.80% | 59.10% | +5.70 | CLGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | -0.70% | +180.70 | CLGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | CLGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.3 | 47.7 | +8.62 | CLGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $12.7M | $17.5M | -$4.8M | HSCS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLGN REV | HSCS REV | CLGN GROSS % | HSCS GROSS % | CLGN FCF | HSCS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.4M | $4.3K | 64.8% | 59.1% | -$9.4M | -$7.4M |
| FY 2024 | $515.0K | $4.3K | -50.0% | 56.8% | -$14.6M | -$7.4M |
| FY 2023 | $11.0M | $18.6K | — | — | -$2.8M | -$6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLGN // BETA —
HSCS // BETA —